Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Moss

Showing results (301-310 of 308) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 308 results.
Journal of Virology|October 22, 2002
Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccinationJamal Baig, Daniel B Levy, Paul F McKay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2013
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunizationKylie M Quinn, Andreia Da Costa, Ayako Yamamoto, et al.
Science Translational Medicine|October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challengeAlec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
The Journal of Infectious Diseases|October 3, 2017
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR BoostJulie A Ake, Alexandra Schuetz, Poonam Pegu, et al.
Cell|November 19, 2013
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeysDan H Barouch, Kathryn E Stephenson, Erica N Borducchi, et al.
Cell|August 27, 2025
Human monoclonal antibodies targeting A35 protect from death caused by mpoxRaianna F Fantin, Meng Yuan, Seok-Chan Park, et al.
Cell|September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primatesEric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
The Journal of Infectious Diseases|April 19, 2018
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara VectorLindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Pageof 31

Showing results (301-310 of 308) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 308 results.
Journal of Virology|October 22, 2002
Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccinationJamal Baig, Daniel B Levy, Paul F McKay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2013
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunizationKylie M Quinn, Andreia Da Costa, Ayako Yamamoto, et al.
Science Translational Medicine|October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challengeAlec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
The Journal of Infectious Diseases|October 3, 2017
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR BoostJulie A Ake, Alexandra Schuetz, Poonam Pegu, et al.
Cell|November 19, 2013
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeysDan H Barouch, Kathryn E Stephenson, Erica N Borducchi, et al.
Cell|August 27, 2025
Human monoclonal antibodies targeting A35 protect from death caused by mpoxRaianna F Fantin, Meng Yuan, Seok-Chan Park, et al.
Cell|September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primatesEric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
The Journal of Infectious Diseases|April 19, 2018
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara VectorLindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Pageof 31